Pygeum — Benefits Deep Dive

Deep-Dive Articles

Table of Contents

1. Deep-Dive Articles
2. The Evidence in One Page
3. Evidence Ledger at a Glance
4. Common Questions, Answered From the Research
5. Key Research: Clinical Trials and the Cochrane Review
6. Key Research: Later Reviews, Favourable and Sceptical
7. Key Research: Bark Chemistry and Laboratory Mechanisms
8. Key Research: Harvesting, Trade and Traditional Use
9. Key Research: Combinations and Other Uses
10. External Resources
11. Connections

The Evidence in One Page

Pygeum is not a plant with no evidence, and it is not a proven treatment either. It sits in an uncomfortable middle position that is common for herbal medicines developed in Europe before modern trial standards.

• The positive case: the Cochrane review found that men taking pygeum were more than twice as likely as men taking placebo to report overall symptom improvement (risk ratio 2.1), with nocturia down 19%, residual urine down 24% and peak urine flow up 23%, and with side effects comparable to placebo.
• The limits: the trials averaged 64 days, only one reported how allocation was concealed, preparations and doses varied, standard validated scores were rarely used, and no trial compared pygeum with alpha-blockers or 5-alpha-reductase inhibitors.
• The sceptical reviews: later reviews of herbal BPH treatments concluded that larger, better-designed studies of phytotherapy found no significant benefit over placebo, and a Spanish systematic review concluded that the evidence did not support phytotherapy for BPH.
• The favourable reviews: a 2023 family-medicine evidence review stated that pygeum "may be effective", and Italian and Spanish urology reviews described it as an option or an add-on.
• The product problem: chemical analysis found commercial extracts differed substantially from the bark, and a German reviewer argued that each manufacturer's extract has to be judged on its own trials.

Back to Table of Contents

Evidence Ledger at a Glance

Human randomised trials (positive, older, small)

• Urinary symptoms and flow in BPH versus placebo — Cochrane review of 18 trials, 1,562 men.
• Once-daily 100 mg versus twice-daily 50 mg — equal at two months in one trial of 209 men.

Human trials of combinations only

• Hair density in pattern hair loss and chronic shedding — one trial of a multi-ingredient capsule; pygeum's own share is unknown.

Laboratory and animal only

• Atraric acid blocking the androgen receptor in a cell test.
• Reduced 5-lipoxygenase inflammatory products from human white blood cells in a dish.
• Slower growth of prostate cancer cell lines; lower cancer incidence in a mouse model.

Absent

• Any human trial of pygeum for preventing or treating prostate cancer.
• Any head-to-head trial against saw palmetto, nettle root or a standard BPH drug.
• Controlled safety data beyond about 12 months, or on drug interactions.

Back to Table of Contents

Common Questions, Answered From the Research

Does pygeum shrink the prostate?

The trials and reviews gathered here report changes in symptoms, urine flow, residual urine and night-time urination, not a measured reduction in prostate size in men. A 2019 review noted that beta-sitosterol, a sterol abundant in some pygeum products, improved symptoms and flow but did not reduce prostate size.

How quickly did trial participants notice a change?

The trials were short — 30 to 122 days, averaging 64 — and the 1990 and 1999 trials reported their main results at about two months. Nothing in the evidence shows whether effects persist or grow over years under placebo control.

Is one daily dose as good as two?

In one 1999 trial of 209 men, 100 mg once daily and 50 mg twice daily performed equally at two months.

Does pygeum prevent prostate cancer?

There is no human evidence that it does. The only data are from prostate cancer cell lines and a mouse model. A 2013 systematic review found no evidence supporting phytotherapy for treating prostate cancer and only experimental work on prevention.

Is it safe?

In the trials, side effects were mild and similar to placebo; the 1990 trial recorded gastrointestinal effects in 5 of 263 men. Long-term safety, drug interactions, and use by anyone other than men with BPH have not been studied.

Are all pygeum products the same?

No. A 2019 chemical analysis found large differences between bark and products, and between products, in sterol and ferulic acid content.

Is buying pygeum a conservation issue?

The tree's bark was overharvested from the wild, and its international trade has required CITES permits since 1995. Researchers argue that only cultivated, traceable supply is sustainable.

Back to Table of Contents

Key Research: Clinical Trials and the Cochrane Review

1. Wilt T, Ishani A, Mac Donald R, et al. Pygeum africanum for benign prostatic hyperplasia. The Cochrane database of systematic reviews. 2002;1998(1):CD001044. PubMed PMID: 11869585
2. Ishani A, MacDonald R, Nelson D, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. The American journal of medicine. 2000;109(8):654-64. PubMed PMID: 11099686
3. Barlet A, Albrecht J, Aubert A, et al. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study]. Wiener klinische Wochenschrift. 1990;102(22):667-73. PubMed PMID: 1702916
4. Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension. Urology. 1999;54(3):473-8. PubMed PMID: 10475357

Back to Table of Contents

Key Research: Later Reviews, Favourable and Sceptical

1. Wilt TJ, Ishani A, Rutks I, et al. Phytotherapy for benign prostatic hyperplasia. Public health nutrition. 2000;3(4A):459-72. PubMed PMID: 11276294
2. Arnold MJ, Gaillardetz A, Ohiokpehai J. Benign Prostatic Hyperplasia: Rapid Evidence Review. American family physician. 2023;107(6):613-622. PubMed PMID: 37327163
3. McNicholas T, Kirby R. Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ clinical evidence. 2011;2011. PubMed PMID: 21871136
4. Keehn A, Taylor J, Lowe FC. Phytotherapy for Benign Prostatic Hyperplasia. Current urology reports. 2016;17(7):53. PubMed PMID: 27180172
5. Keehn A, Lowe FC. Complementary and alternative medications for benign prostatic hyperplasia. The Canadian journal of urology. 2015;22 Suppl 1:18-23. PubMed PMID: 26497340
6. Morán E, Budía A, Broseta E, et al. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma]. Actas urologicas espanolas. 2013;37(2):114-9. PubMed PMID: 23058996
7. Dreikorn K. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Current urology reports. 2000;1(2):103-9. PubMed PMID: 12084323
8. Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World journal of urology. 2002;19(6):426-35. PubMed PMID: 12022711
9. Cicero AFG, Allkanjari O, Busetto GM, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2019;91(3). PubMed PMID: 31577095
10. Salinas-Casado J, Esteban-Fuertes M, Carballido-Rodríguez J, et al. Review of the experience and evidence of Pygeum africanum in urological practice. Actas urologicas espanolas. 2020;44(1):9-13. PubMed PMID: 31627963
11. Game X, Cornu JN, Robert G, et al. [Drug therapy of urethral diseases]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2013;23(15):1287-98. PubMed PMID: 24183087

Back to Table of Contents

Key Research: Bark Chemistry and Laboratory Mechanisms

1. Thompson RQ, Katz D, Sheehan B. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health. Journal of pharmaceutical and biomedical analysis. 2019;163:162-169. PubMed PMID: 30316061
2. Longo R, Tira S. Constituents of Pygeum africanum Bark. Planta medica. 1981;42(6):195-6. PubMed PMID: 17401960
3. Schleich S, Papaioannou M, Baniahmad A, et al. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum. Planta medica. 2006;72(6):547-51. PubMed PMID: 16773539
4. Paubert-Braquet M, Cave A, Hocquemiller R, et al. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. Journal of lipid mediators and cell signalling. 1994;9(3):285-90. PubMed PMID: 7921787
5. Shenouda NS, Sakla MS, Newton LG, et al. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine. 2007;31(1):72-81. PubMed PMID: 17709901
6. Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urological research. 2000;28(3):201-9. PubMed PMID: 10929430
7. Csikós E, Horváth A, Ács K, et al. Treatment of Benign Prostatic Hyperplasia by Natural Drugs. Molecules (Basel, Switzerland). 2021;26(23). PubMed PMID: 34885733

Back to Table of Contents

Key Research: Harvesting, Trade and Traditional Use

1. Stewart KM. The African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal tree? Journal of ethnopharmacology. 2003;89(1):3-13. PubMed PMID: 14522426
2. Cunningham A, Anoncho VF, Sunderland T. Power, policy and the Prunus africana bark trade, 1972-2015. Journal of ethnopharmacology. 2016;178:323-33. PubMed PMID: 26631758
3. Bodeker G, van 't Klooster C, Weisbord E. Prunus africana (Hook.f.) Kalkman: the overexploitation of a medicinal plant species and its legal context. Journal of alternative and complementary medicine (New York, N.Y.). 2014;20(11):810-22. PubMed PMID: 25225776
4. Kassa Z, Asfaw Z, Demissew S. An ethnobotanical study of medicinal plants in Sheka Zone of Southern Nations Nationalities and Peoples Regional State, Ethiopia. Journal of ethnobiology and ethnomedicine. 2020;16(1):7. PubMed PMID: 32024539
5. Adia MM, Savina A, Jane N, et al. Medicinal plant species used for contraception and reproductive health care in rural Uganda. Heliyon. 2025;11(1):e41518. PubMed PMID: 39844971
6. Birhanu L, Moges G, Amsalu N, et al. Woody species diversity, structure and community distribution along environmental gradients of Seqela Dry Afromontane forest in Northwestern Ethiopia. PloS one. 2025;20(1):e0313020. PubMed PMID: 39823466
7. Meragiaw M, Woldu Z, Martinsen V, et al. Woody species composition and diversity of riparian vegetation along the Walga River, Southwestern Ethiopia. PloS one. 2018;13(10):e0204733. PubMed PMID: 30332486

Back to Table of Contents

Key Research: Combinations and Other Uses

1. Piquero-Casals J, Saceda-Corralo D, Aladren S, et al. Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study. Skin appendage disorders. 2025;11(1):27-35. PubMed PMID: 39911983
2. Gasmi A, Mujawdiya PK, Beley N, et al. Natural Compounds Used for Treating Hair Loss. Current pharmaceutical design. 2023;29(16):1231-1244. PubMed PMID: 37151166
3. Yarnell E. Botanical medicines for the urinary tract. World journal of urology. 2002;20(5):285-93. PubMed PMID: 12522584

PubMed Topic Searches

1. PubMed: Pygeum africanum randomized trials
2. PubMed: Prunus africana CITES and harvesting
3. PubMed: Phytotherapy for benign prostatic hyperplasia

Back to Table of Contents

External Resources

• Cochrane Library: Pygeum africanum for benign prostatic hyperplasia, the full systematic review — doi:10.1002/14651858.CD001044
• CITES Appendices — the official lists of species whose international trade is controlled.
• PubMed: all Pygeum africanum and Prunus africana papers — both names, one search.

Back to Table of Contents

Connections

• All Herbs
• Pain and Men's Health Herbs — the category
• Pygeum (Prunus africana) — the main topic page
• BPH Evidence — the trials in detail
• Bark Chemistry and Mechanisms — the laboratory strand
• Overharvesting and CITES — the tree and its trade
• Pygeum vs Saw Palmetto and Nettle — the comparison
• Saw Palmetto Benefits — the most-studied prostate herb
• Nettle Root for Prostate and BPH — the third common BPH herb
• Benign Prostatic Hyperplasia — the condition
• Overactive Bladder — urgency and frequency from the bladder side
• Lycopene and Prostate Health — another nutrient studied for the prostate
• Goldenseal: Sustainability — another medicinal plant strained by wild harvest

Back to Table of Contents